Patterns of methylation profiles as diagnostic markers for multiple hepatocellular carcinomas

References

• Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985;56:918–28.
   Google Scholar
• Lee NW, Wong J, Ong GB. The surgical management of primary carcinoma of the liver. World J Surg 1982;6:66–75.
   PubMedGoogle Scholar
• Nagasue N, Kohno H, Hayashi T, Yamanoi A, Uchida M, Takemoto Y, et al. Lack of intratumoral heterogeneity in DNA ploidy pattern of hepatocellular carcinoma. Gastroenterology 1993;105:1449–54.
   PubMedGoogle Scholar
• Kanai T, Hirohashi S, Upton MP, Noguchi M, Kishi K, Makuuchi M, et al. Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer 1987;60:810–9.
   Google Scholar
• Tsuda H, Hirohashi S, Shimosato Y, Terada M, Hasegawa H. Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma. Gastroenterology 1988 Dec;95:1664–6.
   Google Scholar
• Bourdon JC, D’Errico A, Paterlini P, Grigioni W, May E, Debuire B. p53 protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation. Gastroenterology 1995;108:1176–82.
   PubMedGoogle Scholar
• Matsuda Y, Ichida T, Matsuzawa J, Sugimura K, Asakura H. p16 (INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma. Gastroenterology 1999;116: 394–400.
   Google Scholar
• Herath NI, Kew MC, Walsh MD, Young J, Powell LW, Leggett BA, et al. Reciprocal relationship between methylation status and loss of heterozygosity at the p14(ARF) locus in Australian and South African hepatocellular carcinomas. J Gastroenterol Hepatol 2002;17:301–7.
   PubMedGoogle Scholar
• Tchou JC, Lin X, Freije D, Isaacs WB, Brooks JD, Rashid A, et al. GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas. Int J Oncol 2000;16:663–76.
   PubMedGoogle Scholar
• Goelz SE, Hamilton SR, Vogelstein B. Purification of DNA from formaldehyde fixed paraffin embedded human tissue. Biochem Biophys Res Commun 1985;130:118–26.
   PubMed Web of Science ®Google Scholar
• Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821–6.
   Google Scholar
• Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995;55:4525–30.
   PubMed Web of Science ®Google Scholar
• Esteller M, Tortola S, Toyota M, Capella G, Peinado MA, Baylin SB, et al. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res 2000;60:129–33.
   PubMed Web of Science ®Google Scholar
• Esteller M, Corn PG, Urena JM, Gabrielson E, Baylin SB, Herman JG. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res 1998;58:4515–8.
   Web of Science ®Google Scholar
• Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999;19:271–85.
   PubMed Web of Science ®Google Scholar
• Iwatsuki S, Starzl TE, Sheahan DG, Yokoyama I, Demetris AJ, Todo S, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991;214:221–8.
   PubMed Web of Science ®Google Scholar
• Selby R, Kadry Z, Carr B, Tzakis A, Madariaga JR, Iwatsuki S. Liver transplantation for hepatocellular carcinoma. World J Surg 1995;19:53–8.
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525–32.
   PubMed Web of Science ®Google Scholar
• Bilimoria MM, Lauwers GY, Doherty DA, Nagorney DM, Belghiti J, Do KA, et al. Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg 2001;136:528–35.
   PubMedGoogle Scholar
• Chiappa A, Zbar AP, Audisio RA, Leone BE, Biella F, Staudacher C. Factors affecting survival and long-term outcome in the cirrhotic patient undergoing hepatic resection for hepatocellular carcinoma. Eur J Surg Oncol 2000;26:387–92.
   PubMedGoogle Scholar
• Craig JR. Cirrhosis, hepatocellular carcinoma, and survival. Hepatology 1997;26:798–9.
   PubMedGoogle Scholar
• Okuda T, Wakasa K, Kubo S, Hamada T, Fujita M, Enomoto T, et al. Clonal analysis of hepatocellular carcinoma and dysplastic nodule by methylation pattern of X-chromosome-linked human androgen receptor gene. Cancer Lett 2001;164:91–6.
   PubMedGoogle Scholar
• Lin YW, Chen CH, Huang GT, Lee PH, Wang JT, Chen DS, et al. Infrequent mutations and no methylation of CDKN2A (P16/ MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan. Eur J Cancer 1998;34:1789–95.
   PubMedGoogle Scholar
• Sheu JC, Huang GT, Chou HC, Lee PH, Wang JT, Lee HS, et al. Multiple hepatocellular carcinomas at the early stage have different clonality. Gastroenterology 1993;105:1471–6.
   PubMedGoogle Scholar
• Nakano S, Haratake J, Okamoto K, Takeda S. Investigation of resected multinodular hepatocellular carcinoma: assessment of unicentric or multicentric genesis from histological and prognostic viewpoint. Am J Gastroenterol 1994;89:189–93.
   PubMedGoogle Scholar
• Yasui M, Harada A, Nonami T, Takeuchi Y, Taniguchi K, Nakao A, et al. Potentially multicentric hepatocellular carcinoma: clinicopathologic characteristics and postoperative prognosis. World J Surg 1997;21:860–4.
   PubMedGoogle Scholar
• Okuda T, Hirohashi K, Kinoshita H, Wakasa K, Sakurai M. Characteristic histologic features of human hepatocellular carcinoma with mutant p53 protein. World J Surg 1996;20: 215–20.
   Google Scholar